Evidence map›Paper›PMID 32857105›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Antioxidant Apigenin Relieves Age-Related Muscle Atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal Muscle of Mice.

Dongtao Wang, Yajun Yang, Xiaohu Zou, Jing Zhang, Zena Zheng, Ziwei Wang

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Rumen Fluid Transplantation fromFoods (Basel, Switzerland) · 2026
    Article
  9. A standardized combination ofFood & nutrition research · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Inhibition of CD38 by 78c Enhanced NADInternational journal of molecular sciences · 2025
    Article
  14. Review
  15. Article
  16. Research advances inAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dongtao WangDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Guangdong, China.
Yajun YangDepartment of Pharmacology, Guangdong Key Laboratory for R&D of Natural Drug, Guangdong Medical University, Zhanjiang, China.
Xiaohu ZouDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Guangdong, China.
Jing ZhangDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Guangdong, China.
Zena ZhengDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Guangdong, China.
Ziwei WangDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Guangdong, China.
Southern Medical University Shenzhen Hospital · CNGuangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle atrophy in the aged causes loss in muscle mass and functions. Naturally occurring antioxidant flavonoid apigenin is able to ameliorate obesity- and denervation-induced muscle atrophies, but its effects on age-related muscle atrophy remain unknown. We hypothesized that apigenin can relieve muscle atrophy in aged mice, probably through special effects on reactive oxygen species and enzymes with antioxidant functions. For the male mice of the study, apigenin showed significant dose-dependent effects in relieving aging-related muscle atrophy according to results of frailty index as indicator of frailty associated with aging, grip strength, and running distance. Apigenin also improved myofiber size and morphological features and increased mitochondria number and volume, as manifested by succinate dehydrogenase staining and transmission electron microscopy. Our tests also suggested that apigenin promoted activities of enzymes such as superoxide dismutase and glutathione peroxidase for antioxidation and those for aerobic respiration such as mitochondrial respiratory enzyme complexes I, II, and IV, increased ATP, and enhanced expression of genes such as peroxisome proliferator-activated receptor-γ coactivator 1α, mitochondrial transcription factor A, nuclear respiratory factor-1, and ATP5B involved in mitochondrial biogenesis. The data also suggested that apigenin inhibited Bcl-2/adenovirus E1B 19kD-interacting protein 3 and DNA fragmentation as indicators of mitophagy and apoptosis in aged mice with skeletal muscle atrophy. Together, the results suggest that apigenin relieves age-related skeletal muscle atrophy through reducing oxidative stress and inhibiting hyperactive autophagy and apoptosis.

Indexed as

AnimalsApigeninApoptosisDNA Copy Number VariationsFrailtyMaleMembrane PotentialsMiceMice, Inbred C57BLMitochondriaMitophagyMuscle, SkeletalMuscular AtrophyOxidative StressOxygen ConsumptionReactive Oxygen SpeciesApigeninReactive Oxygen SpeciesApigeninApoptosisMitophagyReactive oxygen speciesSkeletal muscle atrophy

Identifiers

PMID32857105
PMCPMC7566467
OpenAlexW3081708729

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.